HIGHLIGHTS
- who: Chaofeng Liang from the (UNIVERSITY) have published the Article: TOX as a potential target for immunotherapy in lymphocytic malignancies, in the Journal: (JOURNAL)
SUMMARY
TOX (thymocyte selection-associated HMG BOX), a transcription factor, belongs to the high mobility group box (HMG-box) superfamily. In 2002, Wilkinson et_al demonstrated for the first time that TOX plays an important role in the differentiation of CD4 + CD8+ double-positive thymocytes by gene microarray technology. Numerous studies have shown that TOX plays a vital role in the development and formation of various immune organs and cells . . .
If you want to have access to all the content you need to log in!
Thanks :)
If you don't have an account, you can create one here.